Science Explorer Interactive view Map
Company · Cambridge · United States

Merrimack Pharmaceuticals (United States)

World rank, all time
#22,666
of 42,892
Rank in United States
#4,877
of 8,685
Research works
228
▼ 63% vs 2013–17
Citations
5.9k
25.8 per fractional work
Top-10% rate
6.5%
record average 16.5%
Open access
23%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.49× its world share, 1 worksBiochemistry, Geneti…Engineering: 0.58× its world share, 0 worksEngineeringEnvironmental Science: 0.87× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.62× its world share, 0 worksMaterials ScienceMedicine: 1.71× its world share, 1 worksMedicineSocial Sciences: 1.37× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.

Who are the top researchers at Merrimack Pharmaceuticals (United States)?

Ranked on the composite score, Bart S. Hendriks, Charlotte F. McDonagh and Birgit Schoeberl lead among researchers whose main affiliation is Merrimack Pharmaceuticals (United States).

  1. 1 Bart S. Hendriks United States · #302,215 worldwide 115 citations · 20 works
  2. 2 Charlotte F. McDonagh United States · #689,664 worldwide 41 citations · 16 works
  3. 3 Birgit Schoeberl United States · #897,088 worldwide 69 citations · 15 works
  4. 4 Jonathan B. Fitzgerald United States · #932,778 worldwide 46 citations · 18 works
  5. 5 Daryl C. Drummond United States · #1,221,123 worldwide 20 citations · 20 works
All ranked researchers at Merrimack Pharmaceuticals (United States)

Which keywords describe research at Merrimack Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Monoclonal Antibodies, Breast Cancer, Therapeutic Antibodies, Antibody Engineering, Fc Receptors and Monoclonal Antibody.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy36▲ 22×14 topics
  2. Glycosylation32▲ 64×3 topics
  3. Monoclonal Antibodies25▲ 77×3 topics
  4. Breast Cancer25▲ 39×6 topics
  5. Therapeutic Antibodies25▲ 84×2 topics
  6. Antibody Engineering23▲ 102×1 topic
  7. Fc Receptors23▲ 102×1 topic
  8. Monoclonal Antibody22▲ 142×2 topics
  9. Receptor tyrosine kinases22▲ 222×2 topics
  10. Trastuzumab22▲ 222×2 topics
  11. Cancer21▲ 6.6×24 topics
  12. EGFR21▲ 301×1 topic
  13. HER221▲ 301×1 topic
  14. Cancer Therapy16▲ 11×12 topics
  15. Targeted Therapy15▲ 30×4 topics
  16. Immunotherapy15▲ 10×9 topics
  17. Tumor Targeting15▲ 48×3 topics
  18. Nanoparticles13▲ 4.3×7 topics
  19. Tumor Microenvironment10▲ 13×7 topics
  20. Clinical Trials10▲ 7.2×7 topics
  21. Magnetic Nanoparticles8▲ 35×2 topics
  22. Metabolism8▲ 5.5×6 topics
  23. Biomedical Applications8▲ 3.3×4 topics
  24. Metastatic Breast Cancer8▲ 52×2 topics
  25. Drug Delivery8▲ 7.2×3 topics
  26. Surface Engineering8▲ 30×2 topics
  27. Nanocarriers8▲ 77×1 topic
  28. Polymeric Nanoparticles8▲ 77×1 topic
  29. Immune System8▲ 10.0×2 topics
  30. Glycans7▲ 40×1 topic
  31. Mucins7▲ 40×1 topic
  32. Pharmacokinetics7▲ 11×3 topics
  33. Signaling7▲ 25×4 topics
  34. Medicinal Chemistry6▲ 7.3×4 topics
  35. Molecular Docking6▲ 18×1 topic
  36. Virtual Screening6▲ 37×1 topic
  37. Immunity6▲ 7.3×5 topics
  38. PET Imaging6▲ 11×4 topics
  39. ALK Inhibitors5▲ 42×1 topic
  40. EGFR Mutations5▲ 42×1 topic

Which research topics does Merrimack Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques and Lipid Membrane Structure and Behavior.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 0 works
  3. 3 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  4. 4 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 Healthcare and Environmental Waste Management Public Health, Environmental and Occupational Health 0 works
  8. 8 Nanofabrication and Lithography Techniques Biomedical Engineering 0 works
  9. 9 Political and Social Issues Political Science and International Relations 0 works
  10. 10 African Studies and Geopolitics Anthropology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.0%not open77.0%

World: 28% of research is openly available.

with international co-authors11.8%domestic only88.2%

World: 19% is written across borders.

How has Merrimack Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 63% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.